or Try an Advanced Search...

    Antibody Drug Conjugate Stocks List

    Symbol Grade Name % Change
    ADCT B ADC Therapeutics SA 0.42
    TGTX B TG Therapeutics, Inc. 3.40
    CLDX C Celldex Therapeutics, Inc. 3.84
    ACLX C Arcellx, Inc. 2.13
    PYXS D Pyxis Oncology, Inc. 0.23
    MRSN D Mersana Therapeutics, Inc. -0.30
    GMAB F Genmab A/S -3.58
    KPTI F Karyopharm Therapeutics Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Antibody Drug Conjugate stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 5.88
    CNCR C Loncar Cancer Immunotherapy ETF 4.34
    SBIO C ALPS Medical Breakthroughs ETF 3.6
    FBT D First Trust Amex Biotech Index Fund 3.28
    XBI C SPDR S&P Biotech ETF 2.81
    View all Antibody Drug Conjugate ETFs...
    Compare ETFs
    Compare CNCR to SBIO Compare PBE to FBT Compare SBIO to XBI

        Antibody Drug Conjugate Stocks Recent News

        Date Stock Title
        May 2 GMAB Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab reports Q1 results
        May 2 GMAB Genmab Announces Financial Results for the First Quarter of 2024
        May 2 MRSN Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
        May 2 TGTX TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 2 TGTX TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...
        May 2 TGTX Q1 2024 TG Therapeutics Inc Earnings Call
        May 1 GMAB Genmab Q1 2024 Earnings Preview
        May 1 GMAB Genmab: A Complicated Tale
        May 1 TGTX TG Therapeutics jumps as Q1 Briumvi sales top guidance
        May 1 TGTX TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
        May 1 TGTX TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
        May 1 TGTX TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M
        May 1 GMAB Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
        May 1 TGTX TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
        Apr 30 TGTX TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
        Apr 30 KPTI Karyopharm Therapeutics: Spiraling Despite Upcoming Catalysts
        Apr 30 GMAB Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
        Apr 30 TGTX After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)
        Apr 30 GMAB Pfizer, Genmab cervical cancer therapy wins full FDA approval
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics
        Antibody Drug Conjugate

        An Antibody Drug Conjugate (ADC) is a type of targeted therapy used to treat cancer. It is a combination of an antibody, which is a protein that binds to a specific target on cancer cells, and a drug, which is a chemical that kills the cancer cells. The antibody is linked to the drug, allowing it to be delivered directly to the cancer cells. This targeted approach reduces the side effects of traditional chemotherapy, which can damage healthy cells as well as cancer cells.

        Browse All Tags